TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression.

Recently, a non-DNA binding protein, class II transactivator (CIITA), has been shown to be required for constitutive and IFN-gamma-inducible class II MHC transcription. The cytokine TGF-beta inhibits IFN-gamma-induced class II MHC expression at the transcriptional level. In this study, we provide evidence that TGF-beta blocks IFN-gamma-induced CIITA mRNA accumulation. TGF-beta down-regulates class II MHC and CIITA mRNA accumulation in human astroglioma and fibrosarcoma cell lines, but TGF-beta does not destabilize the CIITA message, suggesting an effect at the transcriptional level. In cells that stably overexpressed CIITA, leading to a constitutive class II MHC-positive phenotype, the inhibitory effect of TGF-beta on class II MHC was abrogated, but the cells remained responsive for expression of TGF-beta-inducible genes. Cell lines that possessed defects in TGF-beta signaling also became refractory to inhibition of IFN-gamma-induced CIITA and class II MHC expression. Our data indicate that TGF-beta suppresses IFN-gamma-induced class II MHC expression by inhibiting accumulation of CIITA mRNA.

• Publication year

  1997

• Venue

  Journal of Immunology

• Publication date

  1997-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.4049/jimmunol.158.5.2065PMID 9036950
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors.

  1996cited by this paper
• Regulation of MHC class II genes: lessons from a disease.

  1996cited by this paper
• Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway.

  1996cited by this paper
• Isolation and characterization of mutant cell lines defective in transforming growth factor beta signaling.

  1996cited by this paper
• Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression.

  1996cited by this paper
• Stimulus-specific inhibition of intracellular adhesion molecule-1 gene expression by TGF-beta.

  1996cited by this paper
• HIV glycoprotein 120 enhances intercellular adhesion molecule-1 gene expression in glial cells. Involvement of Janus kinase/signal transducer and activator of transcription and protein kinase C signaling pathways.

  1996cited by this paper
• Stat1 alpha expression is involved in IFN-gamma induction of the class II transactivator and class II MHC genes.

  1996cited by this paper
• Regulation of class II MHC expression.

  1996cited by this paper
• Mechanism of inhibition of eosinophil activation by transforming growth factor-beta. Inhibition of Lyn, MAP, Jak2 kinases and STAT1 nuclear factor.

  1995cited by this paper
• Immune responses in MHC class II-deficient mice.

  1995cited by this paper
• Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA).

  1995cited by this paper
• Identification of a Member of the MAPKKK Family as a Potential Mediator of TGF-β Signal Transduction

  1995cited by this paper
• Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48- kD DNA-binding protein, ISGF3-gamma

  1995cited by this paper
• How are class II MHC genes turned on and off?

  1995cited by this paper
• Evidence for Involvement of Phosphatidylcholine-Phospholipase C and Protein Kinase C in Transforming Growth Factor-β Signaling (*)

  1995cited by this paper
• Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines.

  1995cited by this paper
• Class II transactivator regulates the expression of multiple genes involved in antigen presentation

  1995cited by this paper
• Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency.

  1995cited by this paper
• TGF-beta suppression of IFN-gamma-induced class II MHC gene expression does not involve inhibition of phosphorylation of JAK1, JAK2, or signal transducers and activators of transcription, or modification of IFN-gamma enhanced factor X expression.

  1995cited by this paper
• TGF-beta and endothelial cells inhibit VCAM-1 expression on human vascular smooth muscle cells.

  1995cited by this paper
• Inhibition of macrophage Ia expression by nitric oxide.

  1994cited by this paper
• Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters.

  1994cited by this paper
• Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y.

  1994cited by this paper
• Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction.

  1994cited by this paper
• Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.

  1994cited by this paper
• Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes

  1994cited by this paper
• Transforming growth factor beta 2 stimulates acute and chronic activation of the mitogen-activated protein kinase cascade in rat renal mesangial cells.

  1994cited by this paper
• Signaling mechanisms in thymocyte selection.

  1994cited by this paper
• Differential modulation of astrocyte cytokine gene expression by TGF-beta.

  1994cited by this paper
• Antigen presentation in the central nervous system. The inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed.

  1994cited by this paper
• MHC Class II‐Deficient Combined Immunodeficiency: A Disease of Gene Regulation

  1994cited by this paper
• Mechanism of activation of the TGF-beta receptor.

  1994cited by this paper
• Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro.

  1993cited by this paper
• Repression of major histocompatibility complex IA expression by glucocorticoids: the glucocorticoid receptor inhibits the DNA binding of the X box DNA binding protein

  1993cited by this paper
• Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype.

  1993cited by this paper
• Regulation of MHC gene expression.

  1993cited by this paper
• Inhibition of interferon-gamma-induced major histocompatibility complex class II gene transcription by interferon-beta and type beta 1 transforming growth factor in human astrocytoma cells. Definition of cis-element.

  1993cited by this paper
• Class II MHC transcriptional mutants are defective in higher order complex formation.

  1993cited by this paper
• Signaling events initiated by transforming growth factor-beta 1 that require Gi alpha 1.

  1993cited by this paper
• Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).

  1993cited by this paper
• Transforming growth factor beta 1 repression of the HLA-DR alpha gene is mediated by conserved proximal promoter elements.

  1993cited by this paper
• Sequences and factors: a guide to MHC class-II transcription.

  1992cited by this paper
• Transforming growth factor-beta 1 differentially regulates proliferation and MHC class-II antigen expression in forebrain and brainstem astrocyte primary cultures.

  1992cited by this paper
• Tumor necrosis factor alpha response elements in the HLA-DRA promoter: identification of a tumor necrosis factor alpha-induced DNA-protein complex in astrocytes.

  1992cited by this paper
• Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease

  1992cited by this paper
• Transforming growth factor beta 1-responsive element: closely associated binding sites for USF and CCAAT-binding transcription factor-nuclear factor I in the type 1 plasminogen activator inhibitor gene

  1992cited by this paper
• Interferon-gamma-induced astrocyte class II major histocompatibility complex gene expression is associated with both protein kinase C activation and Na+ entry.

  1991cited by this paper
• Multiple transforming growth factor-beta-inducible elements regulate expression of the plasminogen activator inhibitor type-1 gene in Hep G2 cells.

  1991cited by this paper
• Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

  1991cited by this paper
• Repression of class II major histocompatibility complex genes by cyclic AMP is mediated by conserved promoter elements

  1991cited by this paper
• Transforming growth factors type beta 1 and beta 2 suppress rat astrocyte autoantigen presentation and antagonize hyperinduction of class II major histocompatibility complex antigen expression by interferon-gamma and tumor necrosis factor-alpha.

  1990cited by this paper
• The transforming growth factor-beta family.

  1990cited by this paper
• TGF-beta 1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence.

  1990cited by this paper
• Activation of the cAMP cascade inhibits an early event involved in murine macrophage Ia expression.

  1990cited by this paper
• Induction and regulation of class II major histocompatibility complex mRNA expression in astrocytes by interferon-γ and tumor necrosis factor-α

  1990cited by this paper
• Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway

  1989cited by this paper
• Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells.

  1988cited by this paper
• Transforming growth factor beta stimulates phosphoinositol metabolism and translocation of protein kinase C in cultured astrocytes.

  1988cited by this paper
• Transforming growth factor-beta 2 down-regulates HLA-DR antigen expression on human malignant glioma cells.

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Enhanced production and extracellular deposition of the endothelial- type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta

  1986cited by this paper
• Antagonistic effect of interferon-beta on the interferon-gamma-induced expression of Ia antigen in murine macrophages.

  1985cited by this paper
• Role of MHC gene products in immune regulation.

  1981cited by this paper

• Double, double toil and trouble: transforming growth factor beta (TGF-β) in HIV infection

  2026cites this paper
• In Silico–Designed TGFβRI/TGFβRII Receptor Complex Peptide Inhibitors Exhibit Biological Activity In Vitro

  2025cites this paper
• IL-1β-mediated suppression of CIITA attenuates IFN-γ-induced MHC-II expression on Fibroblasts

  2025cites this paper
• Biology of post-transplant relapse: actionable features.

  2024cites this paper
• Metabolic instruction of the graft-versus-leukemia immunity

  2024cites this paper
• Treg-derived TGF-β1 dampens cGAS-STING signaling to downregulate the expression of class I MHC complex in multiple myeloma

  2024cites this paper
• TGF-β downregulates antigen processing and presentation genes and MHC I surface expression through a Smad3-dependent mechanism

  2023cites this paper
• Combined PD-L1/TGFβ blockade allows expansion and differentiation of stem cell-like CD8 T cells in immune excluded tumors

  2023cites this paper
• Unraveling the peripheral and local role of inflammatory cytokines in glioblastoma survival.

  2022cites this paper
• The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia

  2022cites this paper
• Gene transcripts expressed in equine white blood cells are potential biomarkers of extracorporeal shock wave therapy.

  2021cites this paper
• Immunological Assessment of Chitosan or Trimethyl Chitosan-Coated PLGA Nanospheres Containing Fusion Antigen as the Novel Vaccine Candidates Against Tuberculosis

  2021cites this paper
• Pathogenesis of Brucella epididymoorchitis-game of Brucella death

  2021cites this paper
• Tofacitinib enhances interferon-γ-induced expression of major histocompatibility complex class II in macrophages.

  2021cites this paper
• Targeting immunosuppression by TGF-β1 for cancer immunotherapy

  2021cites this paper
• 异基因造血干细胞移植后复发的免疫逃逸机制及治疗策略

  2021cites this paper
• The role of astrocytes in multiple sclerosis pathogenesis

  2020cites this paper
• Regulatory T Cells in Pregnancy: It Is Not All About FoxP3

  2020cites this paper
• Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation

  2020cites this paper
• Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses

  2020cites this paper
• OTT_A_214231 7281..7288

  2019cites this paper
• Mycobacterium smegmatis But Not Mycobacterium avium subsp. hominissuis Causes Increased Expression of the Long Non-Coding RNA MEG3 in THP-1-Derived Human Macrophages and Associated Decrease of TGF-β

  2019cites this paper
• Mechanisms of immune escape after allogeneic hematopoietic cell transplantation.

  2019cites this paper
• Major histocompatibility complex class II molecule in non-small cell lung cancer diagnosis, prognosis and treatment

  2019cites this paper
• Biology-Driven Approaches to Prevent and Treat Relapse of Myeloid Neoplasia after Allogeneic Hematopoietic Stem Cell Transplantation.

  2019cites this paper
• Targeting Leukemia Stem Cell-Niche Dynamics: A New Challenge in AML Treatment

  2019cites this paper
• Comparing Effects of Transforming Growth Factor β1 on Microglia From Rat and Mouse: Transcriptional Profiles and Potassium Channels

  2018cites this paper
• Cytokines in milk and the role of TGF-beta.

  2018cites this paper
• Investigating the Use of TGF-ß2 to Downregulate MHC Expression and Reduce the Immunogenicity of Equine Bone Marrow-derived Mesenchymal Stem Cells.

  2018cites this paper
• Plasmacytoid dendritic cell in immunity and cancer.

  2018cites this paper
• Transforming Growth Factor-β2 Downregulates Major Histocompatibility Complex (MHC) I and MHC II Surface Expression on Equine Bone Marrow-Derived Mesenchymal Stem Cells Without Altering Other Phenotypic Cell Surface Markers

  2017cites this paper
• TGF- b Family Signaling in Tumor Suppression and Cancer Progression

  2017cites this paper
• Immunomodulatory Activity of VEGF in Cancer.

  2017cites this paper
• The role of astrocytes in multiple sclerosis pathogenesis.

  2017cites this paper
• CML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expression.

  2017cites this paper
• Deletion of TGF-β1 Increases Bacterial Clearance by Cytotoxic T Cells in a Tuberculosis Granuloma Model

  2017cites this paper
• TGF-β Family Signaling in Tumor Suppression and Cancer Progression.

  2017cites this paper
• Participación de los astrocitos en la patogénesis de la esclerosis múltiple

  2017cites this paper
• Understanding the Role of TGF-b1 in Interstitial Lung Disease Using A Multi-Scale Systems Biology Approach

  2017cites this paper
• Investigating the immunoregulatory role of betaglycan

  2016cites this paper
• The immune system and hormone-receptor positive breast cancer: Is it really a dead end?

  2016cites this paper
• Impaired T cell function in malignant pleural effusion is caused by TGF‐β derived predominantly from macrophages

  2016cites this paper
• Fat grafting for breast cancer patients: From basic science to clinical studies.

  2016cites this paper
• Immunomodulation of host-protective immune response by regulating Foxp3 expression and Treg function in Leishmania-infected BALB/c mice: critical role of IRF1.

  2015cites this paper
• Inhibition of CD1d‐mediated antigen presentation by the transforming growth factor‐β/Smad signalling pathway

  2014cites this paper
• Tif1γ regulates the TGF-β1 receptor and promotes physiological aging of hematopoietic stem cells

  2014cites this paper
• Antigen-Pulsed CpG-ODN-Activated Dendritic Cells Induce Host-Protective Immune Response by Regulating the T Regulatory Cell Functioning in Leishmania donovani-Infected Mice: Critical Role of CXCL10

  2014cites this paper
• Adult Human Microglia: Phenotypic Diversity and Functional Complexity

  2013cites this paper
• Osteoimmunology and the infl uence of pro-infl ammatory cytokines on osteoclasts

  2013cites this paper
• Combined chemotherapy and immunotherapy against experimental malignant brain tumors

  2013cites this paper
• The Effect of Mycobacterium avium subspecies paratuberculosis Exposure on Animal Health

  2013cites this paper
• Differential Influence of Inositol Hexaphosphate on the Expression of Genes Encoding TGF-β Isoforms and Their Receptors in Intestinal Epithelial Cells Stimulated with Proinflammatory Agents

  2013cites this paper
• by decoy receptor 3 Epigenetic control of MHC-II expression in tumor-associated macrophages

  2013cites this paper
• Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts

  2013cites this paper
• Adult Human Glia, Pericytes and Meningeal Fibroblasts Respond Similarly to IFNy but Not to TGFβ1 or M-CSF

  2013cites this paper
• Contrasting effects of IFNα on MHC class II expression in professional vs. nonprofessional APCs: Role of CIITA type IV promoter.

  2012cites this paper
• Imipramine Is an Orally Active Drug against Both Antimony Sensitive and Resistant Leishmania donovani Clinical Isolates in Experimental Infection

  2012cites this paper
• Sulphadimidine Suppresses Major Histocompatibility Complex (MHC) Expression in Broiler Chicken

  2012cites this paper
• Identification of candidate Toxoplasma gondii factors that are responsible for the inhibition of IFN-γ mediated up-regulation of MHC Class II

  2012cites this paper
• Adaptive and Innate Transforming Growth Factor (cid:1) Signaling Impact Herpes Simplex Virus 1 Latency and Reactivation (cid:1)

  2011cites this paper
• Regulation and function of class II major histocompatibility complex, CD40, and B7 expression in macrophages and microglia: Implications in neurological diseases

  2011cites this paper
• Efficacy of differential non-invasive approaches in determining the clinical course in patients with Crohn’s disease

  2011cites this paper
• Adaptive and Innate Transforming Growth Factor β Signaling Impact Herpes Simplex Virus 1 Latency and Reactivation

  2011cites this paper
• Could Be Systems-Directed Therapy Approaches Promising in Glioblastoma Patients?

  2010cites this paper
• Transforming growth factor beta (TGF-beta) and inflammation in cancer.

  2010cites this paper
• Antiestrogens induce transforming growth factor beta-mediated immunosuppression in breast cancer.

  2010cites this paper
• Mycobacterium Tuberculosis Infection and Inflammation: what is Beneficial for the Host and for the Bacterium?

  2010cites this paper
• Oncomodulatory mechanisms of human cytomegalovirus in gliomas.

  2010cites this paper
• Genetic Susceptibility in Inflammatory Bowel Disease

  2010cites this paper
• IMMUNOLOGIC MECHANISMS AND PREDICTORS OF SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS

  2009influential citation
• Designing Therapies against Experimental Visceral Leishmaniasis by Modulating the Membrane Fluidity of Antigen-Presenting Cells

  2009cites this paper
• End-Organ Damage in a Mouse Model of Fulminant Liver Inflammation Requires CD4+ T Cell Production of IFN-γ but Is Independent of Fas1

  2009cites this paper
• Effects of immunotherapy of IL-6 and IL-15 plasmids on transmissible venereal tumor in beagles.

  2009cites this paper
• Epigenetic control of MHC-II expression in tumor-associated macrophages

  2008cites this paper
• Epigenetic control of MHC class II expression in tumor-associated macrophages by decoy receptor 3.

  2008cites this paper
• Tumor Suppressor and Pro-progression Roles for TGF-β in Breast Cancer

  2008cites this paper
• Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: A randomized, double-blind, placebo-controlled study

  2008cites this paper
• Expression of cytokines IL-4, IL-12, IL-15, IL-18, and IFNγ and modulation by different growth factors in cultured human osteoblast-like cells

  2007cites this paper
• Novel genetic markers in inflammatory bowel disease.

  2007cites this paper
• Peroxisome Proliferator-activated Receptor γ Interacts with CIITA·RFX5 Complex to Repress Type I Collagen Gene Expression*

  2007cites this paper
• Toll-like receptor triggered dendritic cell maturation and IL-12 secretion are necessary to overcome T-cell inhibition by glioma-associated TGF-beta2.

  2007cites this paper
• Peroxisome proliferator-activated receptor gamma interacts with CIITA x RFX5 complex to repress type I collagen gene expression.

  2007cites this paper
• Toll-like receptor triggered dendritic cell maturation and IL-12 secretion are necessary to overcome T-cell inhibition by glioma-associated TGF-β2

  2007cites this paper
• Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density.

  2007cites this paper
• TGF-β Suppresses IFN-γ-STAT1-Dependent Gene Transcription by Enhancing STAT1-PIAS1 Interactions in Epithelia but Not Monocytes/Macrophages1

  2007cites this paper
• Potential prophylactic and therapeutic vaccines for HSV infections.

  2007cites this paper
• Regulation of MHC Class II Expression and Antigen Processing in Murine and Human Mesenchymal Stromal Cells by IFN-γ, TGF-β, and Cell Density1

  2007cites this paper
• Novel role of TGF‐β in differential astrocyte‐TIMP‐1 regulation: Implications for HIV‐1‐dementia and neuroinflammation

  2006cites this paper
• Estrogen Regulation of Immune Cell Bone Interactions

  2006cites this paper
• Interrelationships and clinical significance of expression of immunological markers in invasive breast carcinoma

  2006cites this paper
• Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma.

  2006cites this paper
• Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer

  2006cites this paper
• Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer.

  2006cites this paper
• The role of T lymphocytes in bone metabolism

  2005cites this paper
• Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients*

  2005cites this paper
• Interferon‐γ‐activated STAT‐1α suppresses MMP‐9 gene transcription by sequestration of the coactivators CBP/p300

  2005cites this paper
• TGF beta signalling and its role in tumour pathogenesis.

  2005cites this paper
• Interferon-gamma-activated STAT-1alpha suppresses MMP-9 gene transcription by sequestration of the coactivators CBP/p300.

  2005cites this paper
• Regulation of MHC class II gene expression by the class II transactivator

  2005cites this paper
• Role of the immune system in postmenopausal bone loss

  2005cites this paper